• Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
    May 28 2025

    Dr Rafael Fonseca from Mayo Clinic in Phoenix, Arizona, discusses datasets from the 2024 ASH meeting on the management of newly diagnosed and relapsed/refractory multiple myeloma.

    CME information and select publications here.

    Show More Show Less
    51 mins
  • 5-Minute Journal Club Issue 8 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
    May 27 2025

    Dr Rinath Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.

    CME information and select publications here.

    Show More Show Less
    14 mins
  • Gastroesophageal Cancer — Fourth Annual National General Medical Oncology Summit
    May 26 2025

    Clinical investigators discuss available data guiding the management of gastroesophageal cancer. 

    CME information and select publications here.

    Show More Show Less
    53 mins
  • Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
    May 24 2025

    Dr Lindsey Roeker from Mayo Clinic in Rochester, Minnesota, discusses recent updates on available and novel treatment strategies for chronic lymphocytic leukemia.

    CME information and select publications here.

    Show More Show Less
    48 mins
  • Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies
    May 23 2025

    Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma.

    CME information and select publications here.

    Show More Show Less
    43 mins
  • Urothelial Bladder Cancer — Fourth Annual National General Medical Oncology Summit
    May 22 2025

    Clinical investigators discuss available data guiding the management of urothelial bladder cancer. 

    CME information and select publications here.

    Show More Show Less
    49 mins
  • Pancreatic Cancer — Fourth Annual National General Medical Oncology Summit
    May 21 2025

    Clinical investigators discuss available data guiding the management of pancreatic cancer. 

    CME information and select publications here.

    Show More Show Less
    49 mins
  • Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies
    May 20 2025

    Dr Jennifer Crombie from the Dana-Farber Cancer Institute in Boston, Massachusetts, reviews available and investigational CD20 x CD3 targeted bispecific antibodies for the treatment of follicular and diffuse large B-cell lymphomas.

    CME information and select publications here.

    Show More Show Less
    50 mins